Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: a propensity-matched analysis.
Xinyu WangChang YinShaofei SuXi LiChao WangChaoli ZhangMeina LiuPublished in: BMC cancer (2018)
The findings of this study suggest that the benefit of additional neoadjuvant or adjuvant RT to chemotherapy may be linked to a proper selection of LA NSCLC patients who undergo surgery. The timing of radiotherapy should be decided on the premise of fully considering patients' condition and the quality of life after treatment.
Keyphrases
- locally advanced
- rectal cancer
- neoadjuvant chemotherapy
- squamous cell carcinoma
- radiation therapy
- phase ii study
- minimally invasive
- early stage
- coronary artery bypass
- end stage renal disease
- ejection fraction
- small cell lung cancer
- newly diagnosed
- prognostic factors
- acute coronary syndrome
- clinical trial
- coronary artery disease
- radiation induced
- atrial fibrillation
- percutaneous coronary intervention
- patient reported outcomes
- study protocol
- lymph node
- tyrosine kinase
- epidermal growth factor receptor